604 related articles for article (PubMed ID: 32849666)
1. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
Front Immunol; 2020; 11():2014. PubMed ID: 32849666
[TBL] [Abstract][Full Text] [Related]
2. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
Nicolau LAD; Magalhães PJC; Vale ML
Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
[TBL] [Abstract][Full Text] [Related]
3. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.
Garvin MR; Alvarez C; Miller JI; Prates ET; Walker AM; Amos BK; Mast AE; Justice A; Aronow B; Jacobson D
Elife; 2020 Jul; 9():. PubMed ID: 32633718
[TBL] [Abstract][Full Text] [Related]
4. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
Hrenak J; Simko F
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
[TBL] [Abstract][Full Text] [Related]
5. Covid-19: the renin-angiotensin system imbalance hypothesis.
Lanza K; Perez LG; Costa LB; Cordeiro TM; Palmeira VA; Ribeiro VT; Simões E Silva AC
Clin Sci (Lond); 2020 Jun; 134(11):1259-1264. PubMed ID: 32507883
[TBL] [Abstract][Full Text] [Related]
6. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
Elife; 2020 Apr; 9():. PubMed ID: 32338605
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.
Franco R; Rivas-Santisteban R; Serrano-Marín J; Rodríguez-Pérez AI; Labandeira-García JL; Navarro G
J Immunol; 2020 Sep; 205(5):1198-1206. PubMed ID: 32680957
[TBL] [Abstract][Full Text] [Related]
8. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
Schmaier AH
J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
[TBL] [Abstract][Full Text] [Related]
9. [Renin Angiotensin Axis, Angiotensin Converting Enzyme 2 and Coronavirus].
Cano F; Gajardo M; Freundlich M
Rev Chil Pediatr; 2020 Jun; 91(3):330-338. PubMed ID: 32730512
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 cytokine storm: The anger of inflammation.
Mahmudpour M; Roozbeh J; Keshavarz M; Farrokhi S; Nabipour I
Cytokine; 2020 Sep; 133():155151. PubMed ID: 32544563
[TBL] [Abstract][Full Text] [Related]
11. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
Steen Burrell KA; Layzer J; Sullenger BA
J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
[TBL] [Abstract][Full Text] [Related]
12. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis.
Delpino MV; Quarleri J
Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170
[No Abstract] [Full Text] [Related]
14. The Plasma Kallikrein-Kininogen Pathway Is Critical in the Pathogenesis of Colitis in Mice.
Wang B; Yang A; Zhao Z; He C; Liu Y; Colman RW; Dai J; Wu Y
Front Immunol; 2018; 9():21. PubMed ID: 29467753
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
16. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System: JACC Review Topic of the Week.
Brojakowska A; Narula J; Shimony R; Bander J
J Am Coll Cardiol; 2020 Jun; 75(24):3085-3095. PubMed ID: 32305401
[TBL] [Abstract][Full Text] [Related]
17. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
Steckelings UM; Sumners C
Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology.
Sohaei D; Hollenberg M; Janket SJ; Diamandis EP; Poda G; Prassas I
Crit Rev Clin Lab Sci; 2023 Jan; 60(1):25-40. PubMed ID: 35930434
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.
Obukhov AG; Stevens BR; Prasad R; Li Calzi S; Boulton ME; Raizada MK; Oudit GY; Grant MB
Diabetes; 2020 Sep; 69(9):1875-1886. PubMed ID: 32669391
[TBL] [Abstract][Full Text] [Related]
20. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
Fang C; Schmaier AH
Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]